The Brachytherapy market, as analyzed by Metastat Insight, represents a significant segment within the broader landscape of cancer treatment technologies. Brachytherapy, a form of radiation therapy, involves the placement of radioactive sources directly into or near the tumor site, delivering targeted radiation to destroy cancer cells while minimizing damage to surrounding healthy tissue. This...
The global oncology companion diagnostic market is expected to grow from its estimated USD 13.30 billion in 2024 to USD 52.16 billion by the end of 2032, according to a report released by Zion Market Research. Over the course of the projection period, the market is anticipated to expand at a CAGR of 16.4%. The study examines the factors that will propel growth, impede it, and affect...
Introduction: Cancer treatment often focuses on eradicating tumors and halting the spread of malignant cells, but the harsh side effects of therapies like chemotherapy, radiation, and immunotherapy can take a significant toll on patients' quality of life. Cancer supportive care drugs, a critical yet sometimes overlooked aspect of cancer care, aim to alleviate these side effects, manage...
OncologyInjectionManufacturs Active ingredient: Recombinant Human Interleukin-11,0.75mg,1.5mg & 3mg with inactive ingredients of Glycine 23 mg, Na2HPO4 0.85 mg, NaH2 PO4 0.48mg per vial. Pharmacology: Recombinant Human Interleukin-11, produced by recombinant DNA technology, is a thrombopoietic growth factor that directly stimulates the proliferation of hematopoietic stem cells and...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά